Peptide Biologix
Compound index
The atlas

Oxytocin Technical Specification Sheet

Oxytocin (α-hypophamine) is a mammalian neurohypophyseal cyclic nonapeptide synthesized in the paraventricular and supraoptic nuclei of the hypothalamus, characterized by an intramolecular Cys1–Cys6 disulfide bridge and C-terminal glycinamide modification.

Engraved study of a small branching coral skeleton with fine surface ridges
Plate 23Oxytocin
Class V — Reproductive & Melanocortin · MW 1007.19 g/mol
AA Sequence (Cyclic Cys1-Cys6) Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Regulatory & Compounding Status (April 2026)

Oxytocin is an FDA-approved prescription drug substance (marketed as Pitocin and Syntocinon for obstetric indications) and an eligible bulk substance when compounded in accordance with federal standards. This monograph documents analytical and biochemical reference parameters strictly for in vitro and preclinical laboratory research.

Molecular Properties

Parameter Specification
Chemical Name Oxytocin / α-Hypophamine
Amino Acid Sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (disulfide bridge: Cys1-Cys6)
Molecular Formula C43H66N12O12S2
Molecular Weight 1007.19 g/mol
CAS Number 50-56-6
Sequence Length 9 amino acids (cyclic nonapeptide with 6-membered ring)
Receptor Targets Oxytocin receptor (OXTR); secondary affinity for vasopressin receptors

Physical Properties

Property Specification
Appearance White to off-white lyophilized powder
Solubility Soluble in water, dilute acetic acid (0.1M), or saline at ≥1 mg/mL; pH 3.0–5.0
pH (1% solution) 3.5–5.0 (acidic for stability)
Hygroscopicity Moderate; desiccated storage required
Solution Stability Stable at 4°C for 5–7 days at pH 3–5; degrades rapidly at neutral/alkaline pH

Analytical Specifications

Test Parameter Method Acceptance Criteria
Purity RP-HPLC (C18 column, 220 nm) ≥98.0%
Molecular Identity ESI-MS or MALDI-TOF MS [M+H]+ = 1007.19 ± 0.5 Da
Peptide Content Amino Acid Analysis / Nitrogen Content ≥95%
Disulfide Bond Integrity Ellman's Reagent (free thiol test) ≥98% oxidized (intramolecular bridge)
Endotoxin Level LAL Assay (USP <85>) <1.0 EU/mg
Acetate Content Ion Chromatography ≤5%
Water Content Karl Fischer Titration ≤5%

Storage Parameters

  • Long-term Storage: -20°C or -80°C in sealed vials under inert atmosphere
  • Short-term Storage: 2–8°C for up to 1 month (lyophilized form)
  • Reconstituted Solution: Store at 4°C (pH 3–5) for ≤7 days or aliquot and freeze at -20°C (avoid repeated freeze-thaw cycles)
  • Protection: Shield from light exposure and alkaline conditions (pH >6 accelerates deamidation and disulfide scrambling)
  • Oxidation Prevention: Maintain disulfide bond integrity by avoiding reducing agents (DTT, β-mercaptoethanol)

Research Dosing Reference

Literature summary of published study doses, routes, and schedules.
Application Typical Dose Range Frequency Route
In Vitro Cell Studies 10–1000 nM Single or repeated exposure Culture media
Small Animal Models (Rodent) 0.1–10 μg/animal (50–500 μg/kg) Acute bolus or continuous infusion IV, IP, SC, intranasal
Behavioral Studies 0.5–5 μg/kg (intranasal); 0.1–1 μg/kg (IV) Single dose 30–60 min pre-testing Intranasal or IV
Myometrial Contractility 1–100 nM (in vitro); 0.5–5 mU/min infusion (in vivo) Continuous infusion Tissue bath or IV pump

Note: Dosing information is for research reference only. Oxytocin is intended strictly for laboratory research. USP activity is typically expressed as Units (U) or milliUnits (mU); 1 mg ≈ 500–600 IU.

Key Research Studies

Year Focus Model Key Findings
1953 Structure determination & synthesis Chemical synthesis (du Vigneaud) First polypeptide hormone sequenced and chemically synthesized
1992 Receptor cloning & characterization Human myometrial cDNA library Cloned oxytocin receptor (OXTR), a Gq-coupled GPCR mediating calcium mobilization (EC50 ~1–5 nM)
2005 CNS social behavior mechanisms Rodent knockout & behavioral models Demonstrated critical role of central OXTR signaling in social recognition, maternal behavior, and pair bonding
2013 Structure-activity relationships Synthetic analogs & receptor binding Identified key residues (Ile3, Leu8) determining selectivity over vasopressin receptors

Mechanism of Action

  • Receptor Binding: Selective agonist at the oxytocin receptor (OXTR, Kd ~1–5 nM), a class A G-protein-coupled receptor (GPCR).
  • Signal Transduction: Couples primarily to Gq/11 proteins, activating phospholipase C-β (PLC-β), generating IP3 and diacylglycerol (DAG), and mobilizing intracellular Ca2+.
  • Peripheral Effects: Stimulates uterine smooth muscle contraction (myometrium) and mammary myoepithelial cell contraction (milk ejection reflex).
  • Central Effects: Modulates neural circuits in the amygdala, nucleus accumbens, and hypothalamus involved in social cognition, stress response, and autonomic regulation.
  • Half-Life: Plasma half-life of 3–5 minutes (IV) due to rapid enzymatic cleavage by oxytocinase (cystinyl aminopeptidase / LNPEP) in liver, kidney, and placental tissue.

Quality Control Parameters

  • Appearance (visual): White to off-white powder; no aggregation
  • Disulfide Bridge Confirmation: ESI-MS shows intact cyclic structure; no reduced form detected
  • RP-HPLC (purity): Main peak ≥98.0%; no single impurity >0.5%
  • Biological Activity (USP): ≥500 IU/mg by rat uterotonic assay
  • Enantiomeric Purity: All L-amino acids; no D-isomer contamination

Comparative Neurohypophyseal Peptides

Oxytocin shares high structural homology with arginine vasopressin (AVP), differing at only two positions (Ile3 vs Phe3; Leu8 vs Arg8). This two-residue substitution accounts for the receptor selectivity between OXTR and V1a/V1b/V2 vasopressin receptors.

Primary Scientific References

  1. du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG, Gordon S. The synthesis of an octapeptide amide with the hormonal activity of oxytocin. J Am Chem Soc. 1953;75(19):4879-4880. DOI: 10.1021/ja01115a553
  2. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629-683. DOI: 10.1152/physrev.2001.81.2.629
  3. National Center for Biotechnology Information. PubChem Compound Summary for Oxytocin. PubChem: Oxytocin